risk 3/5 · target invested 76% — To beat SPY by 5pts on a 30d window I need an overweight in the leading tech complex, but the drawdown constraint argues against full 100% deployment or concentration in extended names (AMD RSI 72, crypto RSI 76-77). Current book is ~66% invested and diversified across 8 tech/index sleeves with all positions green or flat. I top up to ~76% via the steadier momentum leaders (NVDA, MSFT, GOOGL, QQQ) which have positive 5d and 20d relative strength without blow-off RSIs. Keeping ~24% cash buffers drawdown vs SPY while the tech tilt provides the outperformance engine. No adds to AMD/META (short-term negative 5d, elevated ATR) and no chasing crypto proxies.

risk 3/5 · target invested 76% — Beat-and-protect: to outrun SPY by 5pp I need the tech overweight working, but drawdown control requires avoiding the most extended names. Raising invested from ~65% to ~76% by adding to NVDA/MSFT/GOOGL/AAPL — liquid mega-cap leaders with positive relative strength and moderate RSI (61-66). Keeping ~24% cash buffer and no single position near the 30% cap limits drawdown vs SPY if the tape reverses. Holding AMD/META rather than adding after their big runs; not touching crypto at RSI 75+.

buy 0.0517 @ — — alpaca paper order | paper mode

3% of equity, $31 at market

conviction 0.55 — LLM 3% — Starter position in strongest 20d name (+30% rel) on a 4.4% dip from highs; HPE Helios $1.2B order confirms demand. Sized small (3%) because RSI 72.7 is stretched and ATR is high.

risk 3/5 · target invested 76% — Beat-and-protect mandate: need a tech overweight vs SPY to generate the +5pt alpha, but keep ~24% cash and diversified position sizes (all <16% of equity) to hold drawdown below SPY's. Adds are concentrated in the highest rel-strength names on minor pullbacks rather than chasing stretched RSI names in size.

risk 3/5 · target invested 75% — To beat SPY by 5pts on 30d I need overweight in the outperforming tech complex, not benchmark-hugging. Adding measured increments to NVDA/GOOGL/MSFT and a small AMD starter on its 4% dip. Sizing kept moderate (largest position ~15%) and 25% cash retained so a tech pullback produces a shallower drawdown than SPY. No option premium spend needed while equity momentum is delivering.

risk 3/5 · target invested 76% — Sitting at 62.5% invested in a risk-on tape is a drag on the beat-SPY-by-5pp goal. Lifting to ~76% via adds to leadership names (NVDA, META on dip) plus a small, capped AMD starter captures the momentum alpha while ~24% cash keeps drawdown shallower than SPY if the tape turns. Diversification across 7-8 megacap names caps single-name risk well under the 30% limit.

risk 3/5 · target invested 76% — To beat SPY by 5pts I need overweight in the leading tech complex, not cash drag — 63% invested in a risk-on tape lags. Raising to ~76% via adds to QQQ/NVDA/MSFT/GOOGL (strong rel strength, healthy RSI 62-66, not blow-off extended). Keeping ~24% cash plus a 5.8% SPY ballast protects the drawdown side of the mandate. No single position exceeds ~16%, well under the 30% cap. Explicitly skipping overbought AMD/crypto and weak TSLA to avoid mean-reversion drawdown risk.

risk 3/5 · target invested 75% — Raise invested from ~62% to ~75% in a risk_on tape — cash drag loses vs a rising SPY, but a 25% cash buffer plus diversification across 8 names keeps drawdown below the benchmark's. Adds concentrated in names with confirmed relative strength (NVDA, MSFT, AMD starter, META top-up) rather than new speculative themes. No single position exceeds ~14% of equity, well under the 30% cap.

risk 3/5 · target invested 72% — To beat SPY by 5pp I need active tilt, not benchmark hugging — the tech/AI momentum sleeve (QQQ, NVDA, META, AMD, MSFT) provides that. To keep drawdown smaller than SPY's, I hold ~28% cash and cap single-name adds at modest sizes into dips rather than chasing strength. Adding AMD (new, strongest rel strength + fresh order-book catalysts) and topping up META (underweight vs its signal quality). Avoiding TSLA (cash-crunch news, weak momentum) and overbought crypto.

risk 3/5 · target invested 75% — To beat SPY by 5pp on 30d I need concentrated exposure to names with demonstrated relative strength, not benchmark hugging. Moving from ~62% to ~75% invested via adds to AMD, META, and NVDA — the three strongest rel-strength names — while retaining ~25% cash as the drawdown shield. This keeps every position under the 30% cap, avoids weak names (TSLA, AMZN) and overbought crypto, and preserves the smaller-drawdown condition: the cash buffer plus diversified mega-cap quality means my downside beta stays below SPY's while my upside tilt exceeds it.

risk 3/5 · target invested 68% — To beat SPY by 5pp over 30d I need an overweight in relative-strength tech, not benchmark hugging — so I close the SPY sleeve and rotate into AMD (strongest momentum + fresh catalysts) and add to META (best fundamental score, momentum intact). Keeping ~32% cash preserves the smaller-drawdown requirement: if the neutral tape rolls over, cash cushions me versus a fully-invested SPY. Position sizes stay small (largest single name ~12%) to avoid the reckless-concentration failure mode.

risk 3/5 · target invested 70% — Mandate needs +5pp vs SPY with smaller drawdown. Sitting at 62% invested undershoots my own 69-71% target and risks lagging if the tape grinds up. Move to ~70% invested via a small AMD momentum starter on a dip and a QQQ top-up, keeping ~30% cash as the drawdown cushion vs a fully-invested SPY benchmark. Tech tilt supplies the relative return; cash buffer plus position caps (no name >13% of equity) supply the protection.

risk 3/5 · target invested 70% — 62% invested now; adding ~8% via a small AMD starter (strongest momentum name, on a 5d dip) and a low-vol MSFT top-up gets me to ~70%. Full-invested would match SPY's drawdown risk; sitting lower forfeits the relative-return target in a still-constructive tech tape. 70% with a leadership tilt is the balance point.

risk 3/5 · target invested 71% — To beat SPY by 5pp on 30d I need the tech overweight deployed, not idle cash — I'm at 62% invested vs my own 69-70% target, so I top up modestly into the strongest-momentum names. The remaining ~29% cash buffer plus small position sizes (nothing >13%) keeps drawdown shallower than SPY if the bond-stress narrative bites. Small AMD starter on a dip adds alpha optionality without concentration risk; sized at 3% given elevated RSI/ATR.

risk 3/5 · target invested 69% — To beat SPY by 5pp I need an active tilt, not benchmark-hugging — the QQQ/mega-cap tech overweight provides that while leadership persists. To satisfy the smaller-drawdown condition I keep ~30% cash as ballast and avoid extended names (AMD, META adds) and overbought crypto. Nudging from 62% to ~69% invested via the two strongest risk/reward names (MSFT relative strength, NVDA constructive momentum with mid-range RSI) keeps upside participation without concentrating into anything stretched.

risk 3/5 · target invested 69% — Mandate requires beating SPY by 5pp with smaller drawdown. Holding SPY itself is dead weight for relative return, so I rotate it into relative-strength leaders (NVDA, META, small AMD) while keeping ~31% cash as the drawdown buffer. Moderate risk (3/5) reflects the yield-stress backdrop: no leverage-like option buys this cycle, position adds are modest, and every name stays well under the 30% cap. This keeps tracking tilted toward what's outperforming without the concentration that risks failing the drawdown test.

risk 3/5 · target invested 69% — To beat SPY by 5pp with smaller drawdown, I need alpha-generating exposure, not benchmark hugging. Rotating the SPY holding (zero alpha potential) into relative-strength leaders on their dips, while keeping ~30% cash as drawdown protection against the rates/bond-stress overhang. ~69% invested keeps my beta below SPY's while the tech tilt provides the outperformance engine. No single position exceeds ~15%, well under the 30% cap.

risk 3/5 · target invested 70% — To beat SPY by 5pp on a rolling 30d window I need an active tilt, not benchmark hugging — so I rotate the 5.8% SPY sleeve into high relative-strength names (AMD new, META/NVDA adds), lifting invested to ~70%. The ~30% cash buffer is my drawdown defense: with yields at 5.5% and bond-market stress headlines, a rates-driven air pocket is the main tail risk, and holding meaningful cash keeps my drawdown shallower than SPY's if it hits. Sizing is incremental (3-7% clips) into names on modest pullbacks from highs rather than chasing, and every position stays well under the 30% cap. This matches the glide path from my recent stances (62->70%) which has been working — unrealized P/L is positive across the momentum sleeve.

risk 3/5 · target invested 70% — To beat SPY by 5pts I need the QQQ/mega-cap tech overweight working, but the drawdown constraint means I won't go fully invested into 5.5% yields and a possible bond-driven risk-off. ~70% invested with a tech tilt gives outperformance potential in an up-tape while ~30% cash mechanically limits drawdown vs SPY. Small adds to NVDA (buyback catalyst, healthy RSI) and QQQ (broad tech leadership) rather than chasing extended AMD/META or catching falling knives in TSLA/AMZN.

risk 3/5 · target invested 69% — ~69% invested with a megacap tech / QQQ overweight vs SPY: the tilt captures relative strength to build the +5pp gap, while the ~31% cash buffer keeps portfolio drawdown structurally shallower than SPY's in a yield-driven selloff. Adds are small increments into pullbacks on the strongest rel-strength names (NVDA, AMD) rather than a jump in gross exposure, consistent with recent stances at 62-69%.

risk 3/5 · target invested 69% — To beat SPY by 5pp I need an overweight in relative-strength tech, but the 5.5% yield backdrop and drawdown mandate argue against full investment. Moving from 62% to ~69% invested via small adds to the two names with the best momentum/rel-strength profiles that are not overbought (NVDA) or where I'm underweight vs conviction (META). The remaining ~31% cash cushions any yield-driven selloff so my drawdown stays smaller than SPY's.

risk 3/5 · target invested 66% — The beat-and-protect goal requires overweighting the leadership (mega-cap tech/QQQ vs SPY) to generate the +5pp, while ~34% cash cushions a yield-shock drawdown so we stay shallower than SPY. Small NVDA add on its consolidation (RSI 55, strong 10d momentum, not extended) is the only change — avoiding chasing extended AMD/crypto (RSI 69-80) and avoiding TSLA into delivery risk. No churn on existing green positions.

risk 3/5 · target invested 66% — Beat-and-protect mandate: the tech tilt vs SPY is the alpha source and it's working, so I maintain it rather than churn. Staying ~66% invested keeps upside capture if SPY grinds higher while the 34% cash buffer caps drawdown into a binary macro print and 5.5% yield stress. Small MSFT add is the only incremental risk — a relative-strength name at a non-extended RSI. No chasing of AMD/META/crypto froth, no fresh TSLA exposure into delivery risk.

risk 3/5 · target invested 62% — Beat-and-protect: stay ~62% invested so drawdown runs meaningfully below SPY's (effective beta ~0.7-0.75), while the tilt toward relative-strength tech names generates the +5pp spread. Only change this cycle is rotating the redundant SPY hug into MSFT/NVDA — SPY exposure can never create relative return, and both targets show constructive momentum without being overbought. No new aggression into the binary macro print; no chasing extended AMD/crypto (RSI 69-80) which would risk the drawdown condition.

risk 3/5 · target invested 62% — The beat-and-protect mandate needs (1) a source of alpha vs SPY and (2) a smaller drawdown. The existing ~62% invested tech-tilted book provides the alpha leg — every non-SPY position is green and 20d relative strength favors the tilt — while the ~38% cash buffer caps drawdown vs a fully-invested benchmark during rate-stress volatility. Adding exposure into a macro binary with yields at 5.5% would trade drawdown protection for marginal beta; cutting exposure would risk lagging if the print clears and tech resumes. Holding the current structure is the highest-expected-value play; I explicitly avoid chasing AMD (RSI 69 post +30% run) and re-entering TSLA (previously exited, weak tape into deliveries).

risk 3/5 · target invested 66% — Beat-and-protect logic: ~66% invested in a rel-strength tech tilt gives realistic odds of +5pp vs SPY over 30d (tilt names outrunning SPY by 3-30% on 20d), while the ~34% cash buffer mathematically caps my drawdown below SPY's in a selloff and provides dry powder post-PCE. Going to 100% invested into a binary macro print with yields at 5.5% risks failing the drawdown condition; sitting lower than ~60% risks lagging if PCE comes in soft and SPY rips. Small NVDA add is the only change — best momentum-quality setup (RSI 55.8, +7.6% 10d, not overbought) and my strongest existing winner.

risk 3/5 · target invested 62% — Beat: maintain overweight in relatively strong tech (QQQ/NVDA/MSFT/META/GOOGL/AAPL) vs SPY to capture leadership spread. Protect: 38% cash caps drawdown vs a fully-invested benchmark into a binary PCE print and rising-yield stress. Not adding to extended names (AMD RSI 69, crypto RSI 74-77) pre-catalyst, not buying momentum laggards (TSLA/AMZN) without a catalyst, and not churning a book that is uniformly green. Reassess and potentially redeploy cash after the print resolves.

risk 3/5 · target invested 66% — To beat SPY by 5pp on 30d I need the tech tilt to keep compounding relative strength, so I stay ~2/3 invested rather than hiding in cash. To keep drawdown smaller than SPY's, I retain a ~34% cash cushion into the PCE catalyst and avoid extended high-ATR names (AMD RSI 69 after +30% run). Single incremental add: NVDA, the best risk-adjusted momentum in the universe (RSI 56, shallow dip, buyback support), taking it from ~8.5% to ~12.5% of equity — well under the 30% cap. Everything else holds; positions are working and repeating churn adds no edge.

sell 0.1414 @ — — alpaca paper order | exit/risk-reducing — always allowed

conviction 0.00 — LLM close: Weakest name in the book: -7% on 5d, -3.7% rel strength 20d, RSI 39, Q3 deliveries catalyst plus Optimus execution doubts. Cutting it reduces idiosyncratic even

risk 3/5 · target invested 62% — Mandate requires beating SPY by 5pts with smaller drawdown. Keeping ~62% invested with a QQQ/mega-cap tech tilt preserves the outperformance engine while the ~38% cash buffer caps drawdown if PCE comes in hot and yields spike. I trim the weakest holding (TSLA: negative rel strength, deliveries event risk) rather than adding new exposure into a binary macro catalyst. No new buys until the print clears; consistent with my prior stances rather than churning.

risk 3/5 · target invested 62% — Beat-and-protect: keep the overweight in relative-strength tech (vs SPY) to generate the +5pp, but hold ~38% cash buffer into the PCE binary and rising-yield stress so a benchmark drawdown hits me less. Trimming TSLA (weakest momentum, own binary catalyst) rather than the leaders preserves upside capture while lowering tail risk. No new buys blind into the macro print; cash is dry powder to add on a post-PCE dip.

risk 3/5 · target invested 62% — Mandate is beat SPY by 5pp AND hold a smaller drawdown. The tech-tilted core (QQQ/NVDA/MSFT/GOOGL/META/AAPL) is the outperformance engine and is working, so I hold it. The protect leg argues for ~62% invested with ~38% cash cushion into tomorrow's binary PCE print and rising yields — cash buffers drawdown if the print is hot, while 62% deployed in relative-strength names keeps me from underperforming if SPY grinds up. I'm cutting TSLA, the one position with negative relative strength, a looming deliveries catalyst, and deteriorating news flow — it adds drawdown risk without alpha. This completes the measured de-risk from 68%→62% my recent stances have been executing, without churning the winners.

risk 3/5 · target invested 62% — Mandate is beat SPY by 5pp on 30d WITH a smaller drawdown. The tech-tilted core is the alpha source and holds; ~38% cash is the drawdown buffer into a binary macro catalyst with yields rising. Cutting the one laggard (TSLA: weak momentum, negative rel strength, own deliveries catalyst pending) trims idiosyncratic downside without touching the leadership names. Redeploy cash post-PCE if the tape confirms.

risk 3/5 · target invested 65% — Beat-and-protect: ~65% invested in relative-strength tech carries the alpha needed to beat SPY by 5pp, while 35% cash caps drawdown into a binary macro catalyst. Rotating the weakest holding (TSLA: negative rel strength, deliveries risk) into MSFT (positive 5/10d momentum, AI tailwind) improves portfolio quality without raising exposure. Not chasing extended AMD/crypto (RSI 69-79) protects the drawdown side of the mandate.

risk 3/5 · target invested 65% — Mandate is beat SPY by 5pp with smaller drawdown. The SPY sleeve mathematically cannot generate relative alpha, and TSLA is the only clearly broken momentum name in the book (negative rel strength, -6.8% 5d). Rotating those ~11% into NVDA/MSFT (the two strongest-momentum holdings) concentrates the active tilt where it's working, while ~35% cash cushions a PCE-driven drawdown better than the fully-invested benchmark. Avoiding new extended positions (AMD RSI 69, BTC/ETH RSI 74-78) into the print.

risk 3/5 · target invested 67% — Beat-and-protect: ~67% invested in relative-strength tech names should outpace SPY if the rebound continues, while ~33% cash caps downside versus a fully-invested benchmark if PCE runs hot. Opening new positions blind into a binary inflation print risks the drawdown condition; closing working positions (NVDA +8% unrealized, MSFT/GOOGL/QQQ green) would gut the outperformance engine. Holding steady is the highest-expected-value move this cycle; will reassess sizing after the print resolves.

risk 3/5 · target invested 67% — Stay ~67% invested: the tech-tilted book is beating SPY on the rolling window and the cash sleeve caps drawdown ahead of tomorrow's PCE. Adding exposure blind into a binary macro print risks the smaller-drawdown condition; de-risking further risks lagging if SPY rallies on a benign print. Holding the current mix best serves both halves of the beat-and-protect mandate. Will reassess sizing after the PCE reaction — a benign print with tech confirmation would justify deploying part of the cash into leaders (NVDA/QQQ).

risk 3/5 · target invested 68% — Beat-and-protect: staying ~68% invested in relative-strength tech names keeps upside capture vs SPY while the cash buffer caps drawdown into tomorrow's PCE. Only change is rotating the one clear relative-strength laggard (TSLA, rel_strength -3.4%, ret_5 -6.7%) into the strongest risk/reward name (NVDA). No new gross exposure ahead of the binary print — avoids reckless concentration while not hugging the benchmark.

risk 3/5 · target invested 68% — Beat-and-protect: stay overweight leading tech vs SPY to generate relative alpha, but keep ~32% cash buffer ahead of tomorrow's PCE print to keep drawdown shallower than the benchmark if the print is hot. Rotate out of the one laggard (TSLA, negative rel strength) into the strongest non-extended leader (NVDA) rather than raising gross exposure. No fresh option risk into a binary macro event.

risk 3/5 · target invested 70% — To beat SPY by 5pp I need the tech overweight to keep working, so I rotate the weakest relative-strength holding (TSLA, rel_20 -3.4%, RSI 40) into the strongest momentum names (NVDA at a buy point, MSFT +2.5% on 5d). Holding ~30% cash into tomorrow's PCE print caps downside so drawdown stays smaller than SPY's — no new options exposure into a binary macro event.

risk 3/5 · target invested 71% — Beat-and-protect calculus: staying ~70% invested with a tech tilt has produced positive relative P&L (NVDA/MSFT/GOOGL/QQQ all green) while ~29% cash buffers drawdown vs SPY into tomorrow's PCE. Going to 100% into a binary macro print risks a deeper drawdown than the benchmark (auto-fail); going to cash risks lagging if PCE is benign. A small NVDA add sharpens the alpha tilt at the position with the best momentum/RSI balance without materially raising portfolio ATR.

risk 3/5 · target invested 68% — Beat-and-protect: staying ~68% invested in relative-strength tech names captures upside vs SPY while the ~32% cash buffer keeps portfolio drawdown shallower than the benchmark if PCE comes in hot. No gross exposure added; instead I'm rotating out of the weakest holding (TSLA, negative rel strength and -6.3% 5d) into the strongest (NVDA) to sharpen the alpha engine without increasing risk into a macro binary. History shows this stance has held steady with small positive unrealized P/L across the book — no need for a regime-level change, just position-quality improvement.

risk 3/5 · target invested 68% — Beat-and-protect calculus: staying ~68% invested with a QQQ/mega-cap tech tilt keeps upside capture vs SPY while the ~32% cash buffer caps drawdown into a binary PCE print. Going to 100% into the print risks a deeper drawdown than SPY (fail condition); going to cash risks lagging if PCE is benign. I rotate the one negative-relative-strength name (TSLA) into QQQ on a 1.2% dip to concentrate the portfolio in what is actually generating alpha, without raising gross exposure ahead of the catalyst.

risk 3/5 · target invested 70% — Beat-and-protect calculus unchanged: ~70% invested in a diversified mega-cap tech tilt captures the QQQ-vs-SPY relative-strength spread needed for the +5pp goal, while the ~30% cash buffer plus 8-name diversification keeps drawdown shallower than SPY if Fed-hike risk materializes. Extended names (AMD RSI 70.5, ETH RSI 81) are avoided to prevent chasing into a drawdown. Small QQQ top-up restores drift from 67% back to target.

risk 3/5 · target invested 70% — To beat SPY by 5pp I need the tech-alpha tilt working, but the ~30% cash buffer is my drawdown protection against Fed-hike risk — both legs of the mandate. Holding ~67-70% invested keeps beta slightly below SPY while the QQQ/NVDA/META tilt supplies excess return. Rotating the one clear laggard (TSLA, negative rel strength) into NVDA improves the book's relative-strength profile without raising gross exposure or concentration.

buy 0.0866 @ — — alpaca paper order | paper mode

6% of equity, $62 at market

conviction 0.60 — LLM 6% — Best dip-buy in the universe: -8% pullback from highs while 20d rel strength is +24% and fundamental score (0.78) is the highest listed. Buying weakness in a leader rather than chasing extended names;

risk 3/5 · target invested 70% — Currently ~61% invested vs. my standing 70% target. The beat-and-protect goal requires being invested while SPY grinds sideways (cash drag loses if SPY rises), but the ~30% cash buffer plus diversification across 7-8 names caps drawdown below SPY's in a selloff. I top up toward 70% via a META dip-buy (-8% off highs with the strongest fundamental score in the universe at 0.78 and +24% 20d rel strength) rather than chasing extended names (AAPL RSI 76, AMD RSI 71) or averaging into laggards (AMZN downtrend). No options — premium decay in a neutral, choppy tape is a poor trade-off at this account size.

risk 3/5 · target invested 70% — Currently ~61% invested vs 70% target. Adding ~9% via NVDA (buyback catalyst, mid RSI, strong rel strength) and QQQ (diversified tech beta) captures the leadership needed for relative outperformance without concentration risk. 30% cash cushion plus diversification across 7 names keeps expected drawdown below SPY's given SPY itself is choppy; no single position exceeds ~13% of equity.

risk 3/5 · target invested 70% — To beat SPY by 5pts I need overweight in relatively strong tech, but the drawdown constraint and 70% Oct hike odds argue for keeping ~30% cash as ballast. Topping up from 61% to ~70% invested via NVDA and QQQ — the two strongest non-extended holdings — maintains beta-plus-tilt versus SPY while the cash buffer keeps portfolio drawdown shallower than the benchmark if the Fed risk materializes.

risk 3/5 · target invested 70% — To beat SPY by 5pp on rolling 30d while holding smaller drawdown, I run ~70% invested tilted toward relative-strength tech rather than 100% concentration. The ~30% cash buffer mechanically dampens drawdown vs SPY, while the QQQ/NVDA/META tilt provides the alpha engine. This cycle completes deployment toward the 70% target with two catalyst-backed adds: META on an 8% dip with best-in-universe fundamentals/momentum, and NVDA on its $150B buyback plus potential China sales reopening.

risk 3/5 · target invested 70% — To beat SPY by 5pts I need overweight in the tech names that are outrunning it, but the neutral regime and rising-yield pressure warrant a cash cushion so my drawdown stays shallower than SPY's. Holding the existing tilt (NVDA/QQQ/MSFT/GOOGL) and adding one oversold mean-reversion name (AMZN, RSI 38 with October holiday catalysts) gets me to target without concentrating further in extended momentum (AAPL RSI 76, AMD RSI 71). No options this cycle — no cheap defined-risk edge worth the theta in a neutral tape.

risk 3/5 · target invested 70% — To beat SPY by 5pts on 30 days I need overweight in names outperforming the benchmark, not index-hugging. NVDA (buyback + China chip reopening optionality, RSI 53.8 unstretched) and META (-3.5% dip in a +24% relative-strength leader, best fundamentals in universe) are the two clearest alpha sources. Keeping ~30% cash caps drawdown versus a fully-invested SPY holder, satisfying the protect leg. No options — IV-laden structures add decay risk in a neutral chop regime; fractional shares give cleaner exposure.

risk 3/5 · target invested 70% — Beat-and-protect: to out-return SPY by 5pp I need overweight in names with positive 20d relative strength (NVDA, META, QQQ), but the drawdown constraint argues against full deployment or extended names (AAPL RSI 76, AMD RSI 71 post +30% run). 70% invested with diversified 5-13% position sizes keeps single-name risk well under the 30% cap and leaves cash to buy weakness or cushion a selloff, so portfolio drawdown should track shallower than SPY in a downturn while the tech tilt drives relative upside.

risk 3/5 · target invested 70% — Currently ~61% invested vs 70% target. Topping up NVDA (strongest catalyst + moderate RSI) and QQQ (diversified relative-strength beta) closes the gap without concentrating risk. Avoiding overbought AAPL/AMD adds, and avoiding weak-momentum AMZN/GOOGL/TSLA adds. The 30% cash sleeve plus diversified position sizing (largest single name ~12%) keeps portfolio drawdown below SPY's in a pullback while the tech tilt drives relative outperformance if the 10/20d leadership persists.

risk 3/5 · target invested 70% — Sitting at ~61% invested vs my 70% target while SPY chops sideways is a drag on the relative mandate. Completing the scale-in to ~70% via QQQ and NVDA keeps the tech overweight that has been generating the alpha, while the 30% cash buffer plus diversification across 7 names keeps expected drawdown below SPY's (single-name adds are small and beta-adjusted exposure stays moderate). Avoiding overbought high-ATR names (AMD, META) protects the drawdown side of the objective.

risk 3/5 · target invested 70% — To beat SPY by 5pts I need a tech-overweight tilt that has been delivering relative alpha, but the neutral regime and yield/geopolitical noise argue against full deployment. 70% invested in leaders + 30% cash gives upside capture with a structurally smaller drawdown than SPY if the tape rolls over. Currently only ~61% invested, so I'm topping up NVDA and QQQ into their small dips rather than chasing extended names (AMD RSI 71, META +24%/20d, AAPL RSI 76).

risk 3/5 · target invested 70% — To beat SPY by 5pts over 30 days I need overweight exposure to the leadership cohort (NVDA/QQQ/mega-cap tech), not cash-hugging. But the drawdown-protection leg of the mandate argues against full deployment into geopolitical/yield noise — 70% invested with ~30% cash buffer keeps portfolio beta below SPY's on a sharp down day while the tech tilt provides relative alpha on up/flat days. Topping up NVDA and QQQ to reach target rather than opening new extended names.

risk 3/5 · target invested 70% — To beat SPY by 5pts on 30d I need the tech-overweight engine deployed, but the drawdown-protection leg requires a ~30% cash buffer and avoiding extended names. Adding measured size to NVDA (buyback catalyst, RSI 53) and QQQ (diversified relative-strength vehicle) moves me from 61% to ~70% invested without concentrating risk — largest position stays under 15% of equity, well inside the 30% cap.

risk 3/5 · target invested 70% — Mandate requires beating SPY by 5pts on 30d with smaller drawdown. ~70% invested in relative-strength tech gives outperformance potential vs SPY while the ~30% cash sleeve caps drawdown below the benchmark's. Adds go to NVDA (fresh buyback catalyst, RSI 54 not extended) and a small META dip-buy; skip extended AMD and lagging AMZN. No options — IV/catalyst edge not compelling and small account decay risk is real.

risk 3/5 · target invested 70% — At 61% invested I'm below my stated 70% target while the tech-over-SPY thesis is working (all positions green). Under-deployment risks losing to SPY on the upside; full deployment risks drawdown breach given rate volatility. I add ~9pp via QQQ (diversified beta with positive rel strength) and NVDA (strongest catalyst: buyback + ret_10 +9%, RSI 55 not overbought). I avoid extended names (AMD RSI 70 after +30%/20d, AAPL RSI 77) and weak tape (AMZN). No options — IV around rate/Iran noise makes long premium a poor risk/reward for a defined 30-day relative window. Remaining ~30% cash is the drawdown buffer that keeps me ahead of SPY on the protect leg.

risk 3/5 · target invested 70% — To beat SPY by 5pts on a rolling 30d window I need overweight exposure to the leadership complex (semis/QQQ), not benchmark-hugging. But the protect-side of the mandate argues against full investment given yield volatility and geopolitical noise — 70% invested with diversified mega-cap tech, an index sleeve, and 30% cash keeps expected drawdown below SPY's while the rel-strength tilt drives the excess return. Adds are sized small (2.5-4%) so no single position exceeds ~13% of equity, well under the 30% cap.

risk 3/5 · target invested 70% — To beat SPY by 5pp I need active tilt, not cash-hugging — but the mandate also requires a smaller drawdown, so I cap invested at ~70% and spread risk across 8 names with no position above ~13%. Existing book is uniformly green; I add META on its dip (strongest momentum + best value score) and a small NVDA top-up on the buyback catalyst, avoiding overbought/volatile AMD and structurally weak AMZN. The 30% cash reserve directly cushions drawdown vs SPY in a pullback while the tech tilt drives relative return in a grind-up.

risk 3/5 · target invested 72% — At ~61% invested I'm below my ~70-72% target and risk lagging if the tech tape resumes. Deploying ~11% of equity into NVDA (buyback catalyst, RSI 54.9 not stretched) and a starter META dip-buy gets me to ~72% invested — enough tilt vs. SPY to generate outperformance, while ~28% cash plus 8-name diversification (largest position <13%) keeps drawdown shallower than SPY. No options: neutral regime and elevated rates vol argue against premium decay risk.

risk 3/5 · target invested 70% — To beat SPY by 5pp I need the tech tilt working, but the smaller-drawdown condition requires a cash buffer and diversification. ~70% invested across 8 names with no position >13% keeps single-name drawdown risk contained while NVDA buyback and META enterprise-AI catalysts drive relative alpha. Avoiding extended names (AAPL RSI 79, AMD RSI 70 post-blowoff) is the drawdown-protection half of the mandate.

risk 3/5 · target invested 72% — Mandate requires beating SPY by 5pp with a smaller drawdown. A tech-tilted book (QQQ/NVDA/META overweight vs SPY) provides the alpha engine while a ~28% cash buffer and avoidance of overbought names (AAPL RSI 78, AMD RSI 70 post-30% run) caps downside. No positions closed — all holdings are in profit and aligned with the momentum read.

risk 3/5 · target invested 72% — To beat SPY by 5pp I need the tech tilt working, so I stay overweight QQQ/NVDA/MSFT vs. the benchmark. But the drawdown constraint argues against adding to overbought high-ATR names (AMD, META) or AAPL at RSI 79. Adding ~11% of equity split between NVDA (buyback catalyst, RSI 55 = room to run) and MSFT (fresh momentum, RSI 61) brings me from 61% to ~72% invested, matching my recent stance while keeping ~28% cash cushion so any tech pullback produces a shallower drawdown than a fully invested book.

risk 3/5 · target invested 67% — To beat SPY by 5pp I need overweight in relative-strength leaders, not benchmark-hugging or dead-weight laggards. GOOGL is negative across 5/10/20d rel strength - closing it funds adds to NVDA (buyback catalyst), META (dip-buy in strong trend), and QQQ (diversified tech beta). Keeping ~33% cash and diversified position sizes (largest single name ~13%) caps drawdown versus SPY in a neutral/choppy tape, satisfying the protect leg of the mandate.

risk 3/5 · target invested 74% — Beat-and-protect: 74% invested tilted to relative-strength tech gives realistic path to +5pp vs SPY over 30d, while 26% cash and diversified sizing (no position >13%) keeps drawdown shallower than SPY if the neutral regime turns risk-off. Avoiding options premium bleed and avoiding overbought AAPL adds.

risk 3/5 · target invested 70% — To beat SPY by 5pp I need a tech overweight vs the benchmark, which the QQQ/NVDA/MSFT/META relative-strength data supports. But the drawdown-must-be-smaller condition rules out going 100% invested into a neutral regime with oil/yield risk. ~70% invested with a quality-tech tilt gives positive expected alpha while the ~30% cash buffer plus avoidance of overbought (AAPL RSI 81) and extended (AMD +30%/20d) names caps downside vs SPY.

risk 3/5 · target invested 71% — Currently 61% invested vs. 72% standing target — under-invested against a mandate that penalizes cash drag when SPY rises. Adding to NVDA (catalyst + moderate RSI) and starting META (dip in leader) closes the gap to ~71% while keeping ~29% cash buffer and max position ~13.5%, preserving the smaller-drawdown-than-SPY requirement. No adds to extended (AAPL RSI 80) or lagging (AMZN, GOOGL) names.

risk 3/5 · target invested 73% — To beat SPY by 5pp I need a growth/momentum tilt versus the benchmark, not cash drag — current 61% invested is below my 72% plan. Topping up to ~73% via NVDA (fresh buyback catalyst, RSI not extended), QQQ (core outperformance vehicle), and a small META dip-buy achieves the tilt. Keeping ~27% cash plus diversification across 8 names caps drawdown below SPY's in a pullback, satisfying the protect condition. No single position exceeds ~16%, well inside the 30% limit.

risk 3/5 · target invested 72% — Mandate requires beating SPY by 5pp with smaller drawdown. A ~72% invested tech-tilted book gives the beta+alpha tilt needed to outperform while the ~28% cash sleeve mechanically dampens drawdown vs. a fully invested SPY benchmark. Adds concentrated in the two strongest catalyst/relative-strength names (NVDA, AMD) at moderate size; avoiding adds to overbought AAPL (RSI 80) and weakening TSLA.

risk 3/5 · target invested 72% — Beat-and-protect mandate: a moderate tech overweight (NVDA/QQQ) versus the SPY benchmark drives the +5pp relative return goal, while ~28% cash and diversified fractional positions cap drawdown versus SPY. Avoiding overbought AAPL (RSI 81.5, patent verdict), catalyst-negative TSLA (JPM delivery cut), and broken-momentum AMZN keeps risk contained.

risk 3/5 · target invested 72% — To beat SPY by 5pts on 30 days I need active tilt toward relative-strength tech, not cash or benchmark-hugging. But with oil/yield risk and soft breadth, I keep ~28% cash as the drawdown shock absorber — that cash buffer plus diversification across 7 names is how I hold a smaller drawdown than SPY while the QQQ/NVDA tilt generates the spread. Adds are sized small (3-4%) into names with catalysts (NVDA buyback) or steady relative strength (QQQ, MSFT rebounding +1.5% on 5d). No single position exceeds ~13%, well under the 30% cap.

risk 3/5 · target invested 72% — To beat SPY by 5pts on a rolling 30d window I need an active tech overweight, not benchmark hugging — QQQ/NVDA/META relative strength is the clearest edge. But the drawdown condition caps aggression: 72% invested with diversified mega-cap exposure and no single name above ~17% keeps portfolio beta below reckless levels and a cash buffer for pullbacks. Funding adds by closing TSLA (weak momentum, delivery-print risk) improves quality of exposure without raising gross risk much.